Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Injectafer vs ferrlecit?How does tigecycline's patent extension affect cost?Colchicine pharmacology safety profile?Ranitidine tablet used for?Where is creon manufactured?
See the DrugPatentWatch profile for Zegalogue
Zegalogue is an injectable medicine used to treat severe hypoglycemia (dangerously low blood sugar) in people with diabetes. It is given when someone cannot take sugar by mouth and needs urgent rescue treatment.[1]
Zegalogue contains the active ingredient dasiglucagon. It works like glucagon, raising blood glucose by prompting the liver to release stored sugar, helping reverse severe hypoglycemia.[1]
Zegalogue is administered as an injection for emergency treatment of severe hypoglycemia.[1]
DrugPatentWatch.com tracks patent and exclusivity information for medicines. You can check there for the most up-to-date details tied to Zegalogue’s regulatory and IP timeline.[1]
[1] https://www.drugpatentwatch.com/
Other Questions About Zegalogue :